Valuation : Baxter International Inc.

Market Cap 12.61B 10.85B 10.22B 9.31B 17.42B 1,200B 17.49B 121B 46.8B 611B 47.35B 46.32B 1,937B P/E 2026 *
31.3x
P/E 2027 * 20.4x
Enterprise Value 19.51B 16.79B 15.8B 14.4B 26.94B 1,856B 27.05B 187B 72.4B 946B 73.25B 71.66B 2,996B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.6x
Free-Float
75.39%
Yield 2026 *
0.16%
Yield 2027 * 0.16%
1 day-1.89%
1 week-5.10%
Current month-6.19%
1 month-11.47%
3 months+21.77%
6 months+36.18%
Current year+27.63%
1 week 24.39
Extreme 24.39
26.12
1 month 24.39
Extreme 24.39
28.02
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
9/1/26 Tax

President, CCS

-750 0.0001% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.89%-5.10%-0.25%-36.93% 12.61B
-0.27%-4.74%-20.25%+4.47% 182B
-0.54%-0.31%-2.32%+14.92% 118B
-0.42%-3.88%+8.25%+81.95% 61.7B
-0.32%-5.42%+11.66%+43.87% 50.55B
+0.39%-4.12%-5.61%-32.60% 48.98B
-0.77%-6.48%+6.99%-19.62% 31.65B
-1.84%-6.20% - - 29.87B
-0.24%-1.66%+33.69%-14.30% 23.71B
-1.46%-9.42%-13.71%+4.34% 21.78B
Average -0.74%-4.13%+2.05%+5.12% 58.05B
Weighted average by Cap. -0.48%-3.04%-4.39%+12.56%

Financials

2026 *2027 *
Net sales 11.62B 10B 9.41B 8.58B 16.05B 1,105B 16.11B 112B 43.12B 563B 43.62B 42.68B 1,784B 11.86B 10.21B 9.61B 8.76B 16.39B 1,129B 16.45B 114B 44.03B 575B 44.55B 43.58B 1,822B
Net income 372M 320M 301M 275M 514M 35.4B 516M 3.57B 1.38B 18.03B 1.4B 1.37B 57.13B 687M 592M 557M 508M 950M 65.42B 953M 6.6B 2.55B 33.33B 2.58B 2.53B 106B
Net Debt 6.9B 5.93B 5.59B 5.09B 9.53B 656B 9.56B 66.23B 25.6B 334B 25.9B 25.34B 1,059B 6.32B 5.44B 5.12B 4.66B 8.73B 601B 8.76B 60.66B 23.44B 306B 23.72B 23.2B 970B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-09 US$24.39 -1.89% 5,299,244
26-09-08 US$24.86 -3.76% 5,908,322
26-09-04 US$25.83 +1.02% 3,415,196
26-09-03 US$25.57 -0.51% 4,699,471
26-09-02 US$25.70 +0.86% 4,167,853
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
24.39USD
Average target price
28.73USD
Spread / Average Target
+17.78%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!